Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Yep. I think how this GLP-1 kind of super cycle is going to play out if it continues, and what's interesting about the insulin history and the analog to that is It's looking like it's going to be like this ever stacking waves of patentable innovation and product innovation happening here. So like, yes, the semi-glutide patent will expire in 2032.
0
💬
0
Comments
Log in to comment.
There are no comments yet.